2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Are the Primary Drivers Supporting the Market Growth of theACE Inhibitors Market?

The escalating occurrence of high blood pressure ailments is projected to influence the expansion of the ACE inhibitors market. Hypertension, or high blood pressure, is a medical condition defined by an increased tension within the blood channels. ACE inhibitors, synonymous with angiotensin-converting enzyme inhibitors, are a class of drugs used to manage and control hypertension. They operate by calming the blood vessels, leading to a decrease in blood pressure and a betterment in blood circulation. For example, as per the data from the World Health Organization, a UN-affiliated agency based in Switzerland, about 1.28 billion adults between the ages of 30 and 79 dealt with hypertension globally in March 2023, with a majority, two-thirds to be precise, living in low-income to middle-income countries. Over the previous 30 years, there has been a surge of 650 million aged 30-79 people suffering from hypertension. There’s an estimated 46% of adults with hypertension who are unaware of their condition due to a lack of diagnosis. In the last three decades, an added 650 million adults between ages 30 and 79 have been diagnosed with hypertension, and roughly 46% of them remain undiagnosed or unaware of their condition. Hence, the escalating occurrence of hypertensive disorders is propelling the ACE inhibitors market expansion.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10671&type=smp

#What Long-Term Growth Rate is Expected for theACE Inhibitors Market Between 2025 and 2034?

In the past few years, the market size for ACE inhibitors has been expanding consistently. It’s anticipated to expand from $7.15 billion in 2024 to $7.48 billion in 2025, with a compound annual growth rate (CAGR) of 4.6%. Numerous factors have contributed to this growth during the historical period, such as an increase in cases of cardiovascular disease, an aging population, effective clinical outcomes and safety profiles, a higher prevalence of diabetes, and regulatory approvals and guidelines.

The market for ACE inhibitors is predicted to experience significant growth in the upcoming years, with projections suggesting it will reach “$9.6 billion by the year 2029, with a compound annual growth rate (CAGR) of 6.4%. This anticipated growth during the forecast period is attributable to the increasing global prevalence of cardiovascular diseases, broader hypertension treatment protocols, progress in combination therapies, concentration on managing heart failure, and improved awareness and access to healthcare. Key trends forecasted for this period include an emphasis on kidney protection, a preference for renin-angiotensin system inhibitors, the competition and pricing pressures from generics, patient-oriented healthcare strategies, and updates in regulatory and safety measures.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10671

What Are the Latest Innovations Influencing theACE Inhibitors Market?

The ACE inhibitors market is witnessing a surge in product innovations, which is becoming a major trend. The key players in this market are striving to design and launch innovative products to solidify their market standing and acquire a leading edge over their competitors. For instance, in February 2023, the US-based biopharmaceutical corporation Travere Therapeutics received approval from FDA for FILSPARI (sparsentan), a unique non-immunosuppressive therapeutic curated for patients suffering from IgA nephropathy (IgAN). The treatments involved, including systemic glucocorticoids, angiotensin-converting enzyme (ACE) inhibitors, and antihypertensive medicines like angiotensin-receptor blockers (ARBs), make this the only non-immunosuppressive therapy approved to date. This once-daily oral treatment is intended for adults with primary IgAN who are at a high risk of rapid disease progression, typically exhibiting a UPCR less than 1.5 g/g and proteinuria.

Who Are the Major Industry Players Accelerating Growth in theACE Inhibitors Market?

Major companies operating in the ACE inhibitors market include Pfizer Inc., Novartis AG, Johnson & Johnson Private Limited, Merck KGaA, Sanofi S.A., Bayer AG, Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb Co., Takeda Pharmaceuticals Company, Daiichi Sankyo Company Ltd., UCB Schwarz Pharma Inc., Endo International plc, Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim, Bausch Health Companies Inc., Dr. Reddy’s Laboratories, Abbott Laboratories, Eli Lilly and Company, Cipla Limited, GlaxoSmithKline plc, Cadila Healthcare Limited, AbbVie Inc., Sandoz Group AG, Accord Healthcare Ltd., AstraZeneca plc, Lupin Limited, Macleods Pharmaceuticals Limited, Zydus lifescience Ltd., Apotex Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/ace-inhibitors-global-market-report

Which Primary Segments of the ACE Inhibitors Market Are Driving Growth and Industry Transformations?

The ACE inhibitors market covered in this report is segmented –

1) By Type: Sulfhydryl-containing Agents, Dicarboxylate-containing Agents, Phosphonate-containing Agents

2) By Drug: Ramipril, Enalapril, Benazepril, Fosinopril, Captopril, Moexipril, Other Drugs

3) By Dosage Form: Oral Tablets, Oral Solutions

4) By Application: Heart Failure, Chronic Kidney Disease, Hypertension, Diabetes, Heart Attack, Other Applications

5) By End-Users: Hospitals, Online Drug Stores, Other End-Users

Subsegments:

1) By Sulfhydryl-Containing Agents: Captopril, Zofenopril

2) By Dicarboxylate-Containing Agents: Enalapril, Lisinopril, Ramipril, Quinapril, Benazepril, Perindopril

3) By Phosphonate-Containing Agents: Fosinopril

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=10671&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of theACE Inhibitors Market?# Market?

North America was the largest region in the ACE inhibitors market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global ACE inhibitors market report during the forecast period. The regions covered in the ace inhibitors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Gobal ACE Inhibitors Maret 2025, By The Business Research Company:

Surveillance Technology Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/surveillance-technology-global-market-report

Synthetic Biology Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/synthetic-biology-global-market-report

Alpha Mannosidosis Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/alphas-mannosidosis-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: